Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prosaposin like 1 (PSAPL1) is a protein-coding gene annotated in various genomic databases, but there is insufficient evidence for its function, biological relevance, or role as a therapeutic target. The protein shares sequence similarity with saposins and prosaposin family members, but no specific enzymatic, signaling, or receptor function, nor association with disease or pharmacological agents, has been established. The related gene PSAP (prosaposin) encodes a multifunctional protein involved in lysosomal sphingolipid metabolism, neuroprotection, and immune functions, but PSAPL1 does not have such ascribed roles and may be a pseudogene or an uncharacterized homolog[4][1][2][3]. PSAPL1 is not a well-established molecular target, and the available information is likely insufficient for therapeutic or molecular profiling purposes[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prosaposin like 1 (PSAPL1).